Clinical features | |
---|---|
Age (y) | |
Median ± SD (range) | 52 ± 8.7 (34–73) |
< 50 | 42 (39%) |
≥ 50 | 66 (61%) |
Palpability of breast lesion | |
Palpable | 70 (64.8%) |
Non-palpable | 38 (35.2%) |
Palpability of axillary lymph nodes | |
Palpable | 9 (8.3) |
Non-palpable | 99 (91.7%) |
Multicentic breast lesion | |
No | 47 (43.5%) |
Yes | 61 (56.5%) |
Pathologic features | |
Median ± SD (range) [mm] | 21.5 ± 17.1 (2–90) |
T stage | |
T1 (≤20 mm) | 46 (42.6%) |
T2 (> 20 mm, ≤50 mm) | 46 (42.6%) |
T3 (> 50 mm) | 13 (12%) |
T4 | 3 (2.8%) |
N stage | |
N0 | 62 (57.4%) |
N1 | 27 (25%) |
vN2 | 8 (7.4%) |
N3 | 11 (10.2%) |
Variant of ILC | |
Classic | 97 (90%) |
Pleomorphic | 11 (10%) |
Histologic grade | |
I | 7 (6.5%) |
II | 88 (81.5%) |
III | 13 (12%) |